DG DISPATCH - AACAP: Guanfacine Effective For AD/HD And Tic Disorder
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - AACAP: Guanfacine Effective For AD/HD And Tic Disorder

By Lara Pullen
Special to DG News

CHICAGO, IL -- October 26, 1999 -- Although stimulants are the first line of treatment for children with attention deficit/hyperactivity disorder (AD/HD), approximately 30 percent of children fail to respond to stimulants and may demonstrate de novo emergence or worsening of tics following stimulant exposure. Guanfacine appears to be a safe and effective treatment for these children.

At the 46th annual meeting of the American Academy of Child and Adolescent Psychiatry, Dr. Lawrence D. Scahill, of the Yale Child Study Center, described the results of an eight-week, randomized, placebo-controlled trial. The purpose of the trial was to evaluate the efficacy and safety of guanfacine in children with AD/HD and a tic disorder.

The trial comprised 34 medication-free subjects (31 boys and 3 girls) ranging in age from seven to 14 years (mean of 10 years). Primary outcome measures were the DuPaul AD/HD Rating Scale (assessed by the teacher) and the Clinical Global Improvement Score (assessed by the blinded clinician).

At endpoint, nine of 17 subjects on guanfacine were blindly rated as "much improved" or "very much improved" compared to 0 of 17 on placebo. Guanfacine was associated with a 37 percent improvement of AD/HD symptoms.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities